INOVIO to Participate in Upcoming Investor Conferences
November 11, 2026
Biotechnology
-
-
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium
November 11, 2026
-
Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
November 10, 2026
-
Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026
November 5, 2026
-
Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future
November 2, 2026
-
Longeveron Announces Engagement of Lucid Capital Markets
October 28, 2026
-
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
October 27, 2026
-
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
October 23, 2026
-
Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026
October 23, 2026
-
Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
October 21, 2026
-
Oncotelic Keynote to Highlight Partition and Aggregation as a Fundamental Principle for AI Enabled Discovery
October 20, 2026
-
Kane Biotech Signs Distribution Agreement with The Stevens Company
October 20, 2026
-
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
October 20, 2026
-
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
October 19, 2026
-
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
October 19, 2026
-
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
October 16, 2026